BioCentury
ARTICLE | Company News

Arena, Boehringer Ingelheim deal

January 18, 2016 8:00 AM UTC

Arena granted Boehringer exclusive, worldwide rights to develop and commercialize undisclosed oral, small molecules against an undisclosed GPCR. The companies also will conduct joint research to ident...